Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Privacy-aware community infrastructureResearch graph
References from Measurable residual disease-guided, fixed-duration, potentially definitive therapy for standard risk newly diagnosed multiple myeloma. Local targets link to admitted publications; unresolved targets remain external evidence.
10.1200/jco-24-01893
10.1200/jco-24-01893 · 2025 · External reference
10.1182/blood.2024027674
10.1182/blood.2024027674 · 2025 · External reference
10.1111/bjh.70359
10.1111/bjh.70359 · 2026 · External reference
10.1182/bloodadvances.2025018537
10.1182/bloodadvances.2025018537 · 2026 · External reference
10.1016/s2352-3026(23)00236-3
10.1016/s2352-3026(23)00236-3 · 2023 · External reference
10.1056/nejmoa1114083
10.1056/nejmoa1114083 · 2012 · External reference
10.1056/nejmoa1114138
10.1056/nejmoa1114138 · 2012 · External reference
10.1056/nejmoa1402551
10.1056/nejmoa1402551 · 2014 · External reference
10.1056/nejmoa1402888
10.1056/nejmoa1402888 · 2014 · External reference
10.1200/jco.2017.72.6679
10.1200/jco.2017.72.6679 · 2017 · External reference
10.1056/nejmoa2600157
10.1056/nejmoa2600157 · 2026 · External reference
10.1182/blood.2024027620
10.1182/blood.2024027620 · 2025 · External reference
10.1001/jamaoncol.2016.3160
10.1001/jamaoncol.2016.3160 · 2017 · External reference
10.1182/blood.2020010439
10.1182/blood.2020010439 · 2022 · External reference
10.1182/blood.2025029999
10.1182/blood.2025029999 · 2026 · External reference
